JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:JNJ

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	16 : 30	PR Newswire (US)	Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase 2 study	NYSE:JNJ	Johnson and Johnson
2024/06/14	21 : 00	PR Newswire (US)	TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma	NYSE:JNJ	Johnson and Johnson
2024/06/13	03 : 26	Business Wire	Talc Plaintiffs File Motion for Temporary Restraining Order to Limit Johnson & Johnson’s Use of Bankruptcy Strategy	NYSE:JNJ	Johnson and Johnson
2024/06/12	20 : 19	IH Market News	Paramount Ends Skydance Talks, Oracle Shares Surge 8.7% on New Partnerships, and More News	NYSE:JNJ	Johnson and Johnson
2024/06/07	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:JNJ	Johnson and Johnson
2024/06/07	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:JNJ	Johnson and Johnson
2024/06/05	20 : 41	IH Market News	Apollo Buys 49% of Intel’s Irish Plant for $11bn, BlackRock and Citadel to Create Texas Exchange, and More News	NYSE:JNJ	Johnson and Johnson
2024/06/05	05 : 30	Business Wire	Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results	NYSE:JNJ	Johnson and Johnson
2024/05/31	21 : 45	Business Wire	Johnson & Johnson Completes Acquisition of Shockwave Medical	NYSE:JNJ	Johnson and Johnson
2024/05/30	06 : 48	PR Newswire (US)	Sarepta Therapeutics Set to Join S&P MidCap 400	NYSE:JNJ	Johnson and Johnson
2024/05/29	05 : 10	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:JNJ	Johnson and Johnson
2024/05/28	20 : 35	GlobeNewswire Inc.	Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis	NYSE:JNJ	Johnson and Johnson
2024/05/28	20 : 30	Business Wire	Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis	NYSE:JNJ	Johnson and Johnson
2024/05/23	01 : 05	Business Wire	Proposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc Litigation	NYSE:JNJ	Johnson and Johnson
2024/05/21	23 : 43	Edgar (US Regulatory)	Form CERT - Certification by an exchange approving securities for listing	NYSE:JNJ	Johnson and Johnson
2024/05/21	06 : 17	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:JNJ	Johnson and Johnson
2024/05/21	05 : 34	Edgar (US Regulatory)	Form 8-A12B - Registration of securities [Section 12(b)]	NYSE:JNJ	Johnson and Johnson
2024/05/21	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:JNJ	Johnson and Johnson
2024/05/20	22 : 31	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NYSE:JNJ	Johnson and Johnson
2024/05/18	00 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:JNJ	Johnson and Johnson
2024/05/17	20 : 36	IH Market News	OpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More News	NYSE:JNJ	Johnson and Johnson
2024/05/17	05 : 16	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JNJ	Johnson and Johnson
2024/05/16	20 : 30	Business Wire	Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment	NYSE:JNJ	Johnson and Johnson
2024/05/15	06 : 01	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NYSE:JNJ	Johnson and Johnson
2024/05/14	20 : 26	IH Market News	Walmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More News	NYSE:JNJ	Johnson and Johnson
2024/05/14	19 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:JNJ	Johnson and Johnson
2024/05/13	21 : 36	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:JNJ	Johnson and Johnson
2024/05/11	06 : 14	Edgar (US Regulatory)	Form 13F-HR - Quarterly report filed by institutional managers, Holdings	NYSE:JNJ	Johnson and Johnson
2024/05/09	05 : 30	Business Wire	Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	NYSE:JNJ	Johnson and Johnson
2024/05/07	05 : 05	GlobeNewswire Inc.	Shockwave Medical Reports First Quarter 2024 Financial Results	NYSE:JNJ	Johnson and Johnson